These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


424 related items for PubMed ID: 23843565

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Radiosynthesis and biological evaluation of 5-(3-[18F]fluoropropyloxy)-L-tryptophan for tumor PET imaging.
    He S, Tang G, Hu K, Wang H, Wang S, Huang T, Liang X, Tang X.
    Nucl Med Biol; 2013 Aug; 40(6):801-7. PubMed ID: 23791401
    [Abstract] [Full Text] [Related]

  • 3. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M, Trayner BJ, Grant TN, Jans HS, Mercer JR, Murray D, West FG, McEwan AJ, Wuest F, Cheeseman CI.
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [Abstract] [Full Text] [Related]

  • 4. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
    Fukuda H, Matsuzawa T, Abe Y, Endo S, Yamada K, Kubota K, Hatazawa J, Sato T, Ito M, Takahashi T, Iwata R, Ido T.
    Eur J Nucl Med; 1982 May; 7(7):294-7. PubMed ID: 6981508
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE, Wu SY, Chang CW, Liu RS, Hwang LC, Lee TW, Chen JC, Hwang JJ.
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Simple and rapid radiosynthesis of N-18F-labeled glutamic acid as a hepatocellular carcinoma PET tracer.
    Sun A, Liu S, Tang X, Nie D, Tang G, Zhang Z, Wen F, Wang X.
    Nucl Med Biol; 2017 Jun; 49():38-43. PubMed ID: 28301817
    [Abstract] [Full Text] [Related]

  • 9. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
    Li Y, Zhang J, Gu J, Hu K, Huang S, Conti PS, Wu H, Chen K.
    Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
    [Abstract] [Full Text] [Related]

  • 10. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
    McLarty K, Moran MD, Scollard DA, Chan C, Sabha N, Mukherjee J, Guha A, McLaurin J, Nitz M, Houle S, Wilson AA, Reilly RM, Vasdev N.
    Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567
    [Abstract] [Full Text] [Related]

  • 11. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K, Pawlik G, Nebeling B, Rudolf J, Fink G, Hamacher K, Stöcklin G, Heiss WD.
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [Abstract] [Full Text] [Related]

  • 12. 2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis.
    Tahara N, Mukherjee J, de Haas HJ, Petrov AD, Tawakol A, Haider N, Tahara A, Constantinescu CC, Zhou J, Boersma HH, Imaizumi T, Nakano M, Finn A, Fayad Z, Virmani R, Fuster V, Bosca L, Narula J.
    Nat Med; 2014 Feb; 20(2):215-9. PubMed ID: 24412923
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.
    Wang L, Lieberman BP, Ploessl K, Kung HF.
    Nucl Med Biol; 2014 Jan; 41(1):58-67. PubMed ID: 24183614
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
    Menzel MI, Farrell EV, Janich MA, Khegai O, Wiesinger F, Nekolla S, Otto AM, Haase A, Schulte RF, Schwaiger M.
    J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of 2-amino-5-(4-[(18)F]fluorophenyl)pent-4-ynoic acid ([(18)F]FPhPA): a novel (18)F-labeled amino acid for oncologic PET imaging.
    Way JD, Wang M, Hamann I, Wuest M, Wuest F.
    Nucl Med Biol; 2014 Sep; 41(8):660-9. PubMed ID: 24993371
    [Abstract] [Full Text] [Related]

  • 19. Novel synthesis and initial preclinical evaluation of (18)F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent.
    AlJammaz I, Al-Otaibi B, AlHindas H, Okarvi SM.
    Nucl Med Biol; 2015 Oct; 42(10):804-8. PubMed ID: 26160144
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and Bioevaluation of Novel [18F]FDG-Conjugated 2-Nitroimidazole Derivatives for Tumor Hypoxia Imaging.
    Yang X, Wang F, Zhu H, Yang Z, Chu T.
    Mol Pharm; 2019 May 06; 16(5):2118-2128. PubMed ID: 30964298
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.